Chemo–immunotherapy for chemo-resistance and metastasis of triple-negative breast cancer by combination of iron-oxide nanoparticles and dual-targeting doxorubicin liposomes
aKey Laboratory of Drug Targeting and Drug Delivery System of Ministry of Education, West China School of Pharmacy, Sichuan University, Chengdu 610041, China
bSichuan Huiyu Seacross Medical Technology Co., Ltd., Chengdu 610031, China
cSichuan Huiyu Pharmaceutical Co., Ltd., Neijiang 641000, China
dXiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, China
eState Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu 610044, China
收起